Schedule 13D ownership disclosure

ADDEX THERAPEUTICS LTD

Security class unavailable · CUSIP: 00654J107

Event date: 2020-10-25

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
2,867,549
Percent of class
8.7300%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001104659-20-120940
Form type
SC 13D
Filer
Addex Therapeutics Ltd.
CIK
CIK 1574232
Filed
Nov 03, 2020
Reporting period
Oct 25, 2020
Description
Schedule 13D beneficial ownership

Explore SEC Filings Hub